Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol

By Cordeiro Rossana A.   Teixeira Carlos E. C.   Brilhante Raimunda S. N.   Castelo-Branco Débora S. C. M.   Paiva Manoel A. N.   Giffoni Leite João J.   Lima Daniel T.   Monteiro André J.   Sidrim José J. C.   Rocha Marcos F. G.  

Medical Mycology, Vol. 51, Iss. 1, 2013-01 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital

By Arikan Sevtap   Sancak Banu   Hascelik Gulsen  

Medical Mycology, Vol. 43, Iss. 2, 2005-03 ,pp. : 171-178

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans

By Takahata Sho   Okutomi Takafumi   Ohtsuka Keiko   Hoshiko Shigeru   Uchida Katsuhisa   Yamaguchi Hideyo  

Medical Mycology, Vol. 43, Iss. 3, 2005-05 ,pp. : 227-233

Informa Healthcare

Access to resources Recommend Favorite

Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates

By Oz Yasemin   Kiremitci Abdurrahman   Dag Ilknur   Metintas Selma   Kiraz Nuri  

Medical Mycology, Vol. 51, Iss. 1, 2013-01 ,pp. : 60-65

Informa Healthcare

Access to resources Recommend Favorite

Antifungal activity of low molecular weight chitosan against clinical isolates of Candida spp.

By Alburquenque Claudio   Bucarey Sergio A.   Neira-Carrillo Andrónico   Urzúa Blanca   Hermosilla Germán   Tapia Cecilia V.  

Medical Mycology, Vol. 48, Iss. 8, 2010-12 ,pp. : 1018-1023

Informa Healthcare

Access to resources Recommend Favorite